TY - GEN
T1 - Correction to
T2 - Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
AU - Silverberg, Jonathan I
AU - Thyssen, Jacob P
AU - Simpson, Eric L
AU - Yosipovitch, Gil
AU - Ständer, Sonja
AU - Valdez, Hernan
AU - Rojo, Ricardo
AU - Biswas, Pinaki
AU - Myers, Daniela E
AU - Feeney, Claire
AU - DiBonaventura, Marco
PY - 2021/9
Y1 - 2021/9
N2 - Page 550, Fig. 4: The legend, which previously read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI)
a and b Children’s Dermatology Life Quality Index (CDLQI)
b band descriptors.
aFor patients ≥ 8 years of age.
bFor patients < 18 years of age. Should read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI)
a and b Children’s Dermatology Life Quality Index (CDLQI)
b band descriptors.
aFor patients ≥ 18 years of age.
bFor patients < 18 years of age.
AB - Page 550, Fig. 4: The legend, which previously read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI)
a and b Children’s Dermatology Life Quality Index (CDLQI)
b band descriptors.
aFor patients ≥ 8 years of age.
bFor patients < 18 years of age. Should read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI)
a and b Children’s Dermatology Life Quality Index (CDLQI)
b band descriptors.
aFor patients ≥ 18 years of age.
bFor patients < 18 years of age.
UR - http://www.scopus.com/inward/record.url?scp=85112825822&partnerID=8YFLogxK
U2 - 10.1007/s40257-021-00634-3
DO - 10.1007/s40257-021-00634-3
M3 - Other contribution
C2 - 34406620
VL - 22
T3 - American Journal of Clinical Dermatology
ER -